The real additional value of FDG-PET in detecting the occult primary tumour in patients with cervical lymph node metastases of unknown primary tumour.
de Bree
Remco
R
D001706:Biopsy; D002294:Carcinoma, Squamous Cell / Q000000981:diagnostic imaging* / Q000556:secondary*; D003952:Diagnostic Imaging; D004724:Endoscopy; D005188:False Negative Reactions; D005189:False Positive Reactions; D019788:Fluorodeoxyglucose F18; D006258:Head and Neck Neoplasms / Q000000981:diagnostic imaging* / Q000556:secondary; D006801:Humans; D008198:Lymph Nodes / Q000000981:diagnostic imaging; D008207:Lymphatic Metastasis / Q000000981:diagnostic imaging*; D009382:Neoplasms, Unknown Primary / Q000000981:diagnostic imaging*; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals; D012680:Sensitivity and Specificity
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18
Head Neck. 2008 Jan;30(1):28-34
17657782
Cancer. 2004 Dec 1;101(11):2641-9
15517576
Eur Arch Otorhinolaryngol. 2010 Nov;267(11):1785-92
20814690
J Nucl Med. 2009 May;50 Suppl 1:11S-20S
19380405
Mol Imaging Biol. 2005 May-Jun;7(3):244-56
15912429
Radiother Oncol. 2008 May;87(2):221-9
18410977
Eur Arch Otorhinolaryngol. 2009 Feb;266(2):267-71
18587594
Eur J Nucl Med Mol Imaging. 2002 Aug;29(8):1024-30
12173016